Drug Trial Radar · NCT07202546
A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study)
Last checked: Nov 20, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
186
Planned (sponsor's estimate)
Start
Feb 11, 2026
Primary completion
Oct 28, 2027
Study completion Jul 9, 2032
Sponsor
- Lead sponsor
- ViiV HealthcareGSK (GSK)
- Sponsor type
- Industry
- First posted
- Oct 2, 2025
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This clinical study is testing a new medication, VH4524184, to see if it can effectively treat HIV-1 in adults who have never received treatment for their infection. The study is comparing two different doses of VH4524184, each taken with the medications emtricitabine and tenofovir alafenamide (FTC/TAF), to a standard HIV treatment called dolutegravir and lamivudine (DTG/3TC). The purpose of the study is to provide data on the long-term antiviral activity of the VH4524184 and provide information regarding dosing formulation for further evaluations.
Conditions
- HIV Infections
Interventions
VH4524184Drug
Oral tablet will be administered.
Emtricitabine (FTC) and tenofovir alafenamide (TAF) Fixed Dose Combination (FDC) tabletsDrug
Oral table will be administered.
Dolutegravir / Lamivudine (DTG/3TC)Drug
Oral tablets will be administered.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Participants Achieving Plasma Human Immunodeficiency Virus-1 (HIV-1) Ribonucleic Acid (RNA) Suppression (<50 copies/millilitre) as per FDA Snapshot MethodologyTime frame: At Month 12
Locations
125 sites in 14 countries. Site status is shown where the registry gives one.
GSK Investigational Site
Bakersfield, California · Recruiting
GSK Investigational Site
Palm Springs, California · Recruiting
GSK Investigational Site
West Hollywood, California · Recruiting
GSK Investigational Site
Aurora, Colorado · Recruiting
GSK Investigational Site
New Haven, Connecticut · Recruiting
GSK Investigational Site
Ft. Pierce, Florida · Recruiting
GSK Investigational Site
Hollywood, Florida · Recruiting
GSK Investigational Site
Miami, Florida · Recruiting
GSK Investigational Site
Miami Gardens, Florida · Recruiting
GSK Investigational Site
Oakland Park, Florida · Recruiting
GSK Investigational Site
Orlando, Florida · Recruiting
GSK Investigational Site
Orlando, Florida · Recruiting
GSK Investigational Site
West Palm Beach, Florida · Recruiting
GSK Investigational Site
Atlanta, Georgia · Recruiting
GSK Investigational Site
Macon, Georgia · Recruiting
GSK Investigational Site
Chicago, Illinois · Recruiting
GSK Investigational Site
Louisville, Kentucky · Completed
GSK Investigational Site
Columbia, Missouri · Recruiting
GSK Investigational Site
Kansas City, Missouri · Recruiting
GSK Investigational Site
Omaha, Nebraska · Recruiting
GSK Investigational Site
Hackensack, New Jersey · Recruiting
GSK Investigational Site
Newark, New Jersey · Recruiting
GSK Investigational Site
Albany, New York · Recruiting
GSK Investigational Site
Manhasset, New York · Recruiting
GSK Investigational Site
Charlotte, North Carolina · Recruiting
GSK Investigational Site
Durham, North Carolina · Recruiting
GSK Investigational Site
Greensboro, North Carolina · Recruiting
GSK Investigational Site
Wilmington, North Carolina · Recruiting
GSK Investigational Site
Cincinnati, Ohio · Recruiting
GSK Investigational Site
Bellaire, Texas · Recruiting
GSK Investigational Site
Dallas, Texas · Recruiting
GSK Investigational Site
Houston, Texas · Recruiting
GSK Investigational Site
Houston, Texas · Recruiting
GSK Investigational Site
Longview, Texas · Recruiting
GSK Investigational Site
Seattle, Washington · Recruiting
GSK Investigational Site
Buenos Aires, Argentina · Recruiting
GSK Investigational Site
Buenos Aires, Argentina · Recruiting
GSK Investigational Site
Buenos Aires, Argentina · Recruiting
GSK Investigational Site
Ciudad Autonoma Buenos Aires, Argentina · Recruiting
GSK Investigational Site
Ciudad Autonoma de Bueno, Argentina · Recruiting
Showing 40 of 125 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.